Neupopeg Európai Unió - dán - EMA (European Medicines Agency)

neupopeg

dompé biotec s.p.a. - pegfilgrastim - neutropenia; cancer - immunostimulants, - reduktion i varigheden af neutropeni og forekomst af febril neutropeni hos patienter behandlet med cytotoksisk kemoterapi for malignitet (med undtagelse af kronisk myeloid leukæmi og myelodysplastisk syndromer).

Lamictal 100 mg tyggetabletter/dispergible tabletter Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

lamictal 100 mg tyggetabletter/dispergible tabletter

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 100 mg

Lamictal 200 mg tyggetabletter/dispergible tabletter Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

lamictal 200 mg tyggetabletter/dispergible tabletter

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 200 mg

Lamictal 25 mg tyggetabletter/dispergible tabletter Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

lamictal 25 mg tyggetabletter/dispergible tabletter

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 25 mg

Lamictal 50 mg tyggetabletter/dispergible tabletter Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

lamictal 50 mg tyggetabletter/dispergible tabletter

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 50 mg

Lamictal 5 mg tyggetabletter/dispergible tabletter Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

lamictal 5 mg tyggetabletter/dispergible tabletter

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 5 mg